ARCUTIS BIOTHERAPEUTIC
10.15
20-September-24 15:59:59
15 minutes delayed
Stocks
+0.01
+0.10%
Today's range
9.78 - 10.31
ISIN
N/A
Source
NASDAQ
-
29 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
22 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
14 Jan 2024 04:00:00 By Nasdaq GlobeNewswire
-
14 Jan 2024 04:00:00 By Nasdaq GlobeNewswire
-
15 Dec 2023 17:11:43 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Dec 2023 22:00:49 By Nasdaq GlobeNewswire
-
29 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2023 Financial Results and Provides Business Update
03 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Nov 2023 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis to Report Third Quarter 2023 Financial Results
25 Oct 2023 16:00:00 By Nasdaq GlobeNewswire
-
20 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis Announces Pricing of $100 Million Public Offering
19 Oct 2023 23:45:47 By Nasdaq GlobeNewswire
-
Arcutis Announces Proposed Public Offering
19 Oct 2023 16:04:44 By Nasdaq GlobeNewswire
-
06 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Oct 2023 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis Appoints L. Todd Edwards as Chief Commercial Officer
27 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
25 Sep 2023 09:00:47 By Nasdaq GlobeNewswire
-
19 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 Sep 2023 16:00:00 By Nasdaq GlobeNewswire